138951-96-9

Upstream product

• 53750-13-3 5,5-diphenyl-2-cyclopenten-1-one 
• 50790-27-7 2,2-diphenyl-4-pentenoyl chloride 
• 6966-03-6 2-allyl-2,2-diphenylacetic acid 

Downstream Products

• 138951-97-0 5,5-diphenyl-2-cyclopentenyl acetate 
• 138951-50-5 (R,S)-N-tert-butyl-4,4-diphenyl-2-cyclopentenylamine 
• 1027148-08-8 Methanesulfonic acid 5,5-diphenyl-cyclopent-2-enyl ester 
• 138951-98-1 4,4-diphenyl-2-cyclopentenyl azide 
• 71516-78-4 5,5-Diphenyl-cyclopentadien 
• 326595-91-9 4,4-diphenyl-2-cyclopenten-1-ol 

Relevant academic research and scientific papers

Agents for the treatment of overactive detrusor. V. Synthesis and inhibitory activity on detrusor contraction of N-tert-butyl-4,4-diphenyl-2- cyclopentenylamine

N-tert-Butyl-4,4-diphenyl-2-cyclopentenylamine ((±)-3) was designed to restrict the conformation of terodiline I and was synthesized in a 6-step approach starting with diphenylacetaldehyde (10) or in a 4-step approach starting with 2,2-diphenyl-4-pentenoi

Agents for the treatment of overactive detrusor. VIII. Synthesis and pharmacological properties of 4,4-diphenyl-2-cycloalkenylamines including FK584 and 3,3- or 4,4-diphenylcycloalkylamines

This article describes the synthesis of 4,4-diphenyl-2-cycloalkenylamines (3, 5a) including PK584 (S(-)-3a) and 3,3- or 4,4-diphenylcycloalkylamines (2, 4, 5b), and their inhibitory activities against detrusor contraction. The order of inhibitory activity

Substituted-amine compound and a process for the preparation thereof

The compound (-)-N-t-butyl-4,4-diphenyl-2-cyclopentenylamine, or its hydrochloride salt has anticholinergic activity, and thus has a variety of pharmaceutical utilities.